We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

13 hedge funds and large institutions have $879K invested in Grace Therapeutics in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $577K → $879K (+$303K)

0.03% more ownership

Funds ownership: 0.04% → 0.07% (+0.03%)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$548K
2
Citadel Advisors
Citadel Advisors
Florida
+$26.1K
3
PA
Perceptive Advisors
New York
+$16.1K
4
Renaissance Technologies
Renaissance Technologies
New York
+$14.9K
5
VF
Virtu Financial
New York
+$10.6K

Top Sellers

Rank Fund Capital Flow
1
JMPWA
JP Morgan Private Wealth Advisors
California
-$28K
2
Wells Fargo
Wells Fargo
California
-$9K
3
ASN
Advisory Services Network
Georgia
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$527K +$548K +14,263 New
PA
2
Perceptive Advisors
New York
$117K +$16.1K +419 +11%
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$88K – – –
IIM
4
Intact Investment Management
Quebec, Canada
$37K – – –
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$28K – – –
Morgan Stanley
6
Morgan Stanley
New York
$23K – – –
VF
7
Virtu Financial
New York
$23K +$10.6K +275 +47%
Citadel Advisors
8
Citadel Advisors
Florida
$19K +$26.1K +680 New
Renaissance Technologies
9
Renaissance Technologies
New York
$11K +$14.9K +388 New
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$3K +$1.11K +29 +34%
UBS Group
11
UBS Group
Switzerland
$3K +$2.81K +73 +348%
RE
12
RBC Europe
United Kingdom
$17 – – –
JMPWA
13
JP Morgan Private Wealth Advisors
California
– -$28K -563 Closed
Wells Fargo
14
Wells Fargo
California
– -$9K -180 Closed
ASN
15
Advisory Services Network
Georgia
– -$5K -104 Closed
Toronto Dominion Bank
16
Toronto Dominion Bank
Ontario, Canada
– +$38 +1 +100%

GRCE Hedge Fund Activity: Q2 2018 in Review

13 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2018, worth a combined $879K — up 52% from $577K a quarter earlier.

Fund positioning in GRCE was balanced in Q2 2018: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $548K. The largest seller was JP Morgan Private Wealth Advisors, exiting entirely with an estimated $28K sold.

  • 13 institutional investors held Grace Therapeutics (GRCE) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $879K of Grace Therapeutics stock for Q2 2018, up 52% quarter-over-quarter.
  • 3 funds opened new Grace Therapeutics positions in Q2 2018 and 3 closed out, a net change of 0 holders.
  • The largest Grace Therapeutics buyer in Q2 2018 was Anson Funds Management, an estimated $548K added.
  • The largest Grace Therapeutics seller in Q2 2018 was JP Morgan Private Wealth Advisors, an estimated $28K sold.

Based on aggregated 13F filings for Q2 2018.